Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes.
about
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science studyMantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsMantle cell lymphoma with in situ or mantle zone growth pattern: a study of five cases and review of literatureIndolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behaviorDistinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometryToll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.Nodal aggressive B-cell lymphomas: a diagnostic approachChronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disordersEarly lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.Molecular outcome prediction in mantle cell lymphoma.The current lymphoma classification: new concepts and practical applications triumphs and woes.In situ mantle cell lymphoma in the nasopharynx.Indolent mantle cell lymphoma.A rare presentation of in situ mantle cell lymphoma and follicular lymphoma: a case report and review of the literatureSynchronous pulmonary squamous cell carcinoma and mantle cell lymphoma of the lymph node.Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma.Analysis of immunoglobulin V genes suggests cutaneous marginal zone B-cell lymphomas recognise similar antigens.Smoldering mantle cell lymphoma.Observation as the initial management strategy in patients with mantle cell lymphoma.Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index.No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo.
P2860
Q33572807-8BF66653-7869-4C01-B483-9F448F3CBD9EQ33586239-35C359F6-3C31-4315-84C1-363E59ED51ABQ34074921-BBD46A77-DB77-447E-B3EA-5BE7CC4223E0Q35029409-98BE1B11-16DE-4B7F-AE59-DF7EA6EB118CQ35138873-BE705982-3AB7-4981-8CC5-A008E2821A54Q35143462-944634A0-E9CE-4F2A-8C16-BB3CD0AC3A97Q35717870-4ACAD399-20C0-4F46-9763-9E9100B423EAQ35809271-E23CB691-A457-457D-B289-DA2E63F5BEF8Q36001708-4588E586-9AB6-4135-835E-49D754B6F9F7Q36216258-D78E1654-0C42-4257-B554-5D2AC0BCCB70Q36763463-023E60F7-8EC9-4A27-9FB7-49863E896771Q36979738-AB6EF95F-8CA0-48AB-A71B-076E573A908AQ37171576-2C5EBEDE-0DE6-41F7-B39F-934E885ED389Q37352773-528409DA-8308-4E9A-AB9D-00610E23FCD8Q37401338-76F3E9EB-172C-4166-877A-D48B2F04DEABQ38010331-601E79FD-52DE-426D-A0A6-242AED91C2D4Q38071003-8DDF2ADB-1AF3-4EDB-BC0F-5A60FCE18AFDQ38127446-15C22A24-D3D9-4248-8EAC-851B071B5B2AQ38283586-9C05BE91-61E3-4227-A5AD-3DD0959EB597Q42326541-C8527723-DDDE-444A-817D-7BB3ADD73806Q44293063-D9332737-E464-4B8E-B062-2C3627A853B5Q44670276-73C230A7-8240-48FD-B261-747DC6F72F4FQ47111277-3A4CAA01-D4C5-489B-9B25-A005F9EB8AF3Q48646624-25326DA6-DCAC-440E-A94A-318BD3735794Q53099339-2F24F44A-D74E-4FA9-8622-11EB416EF363Q53099728-25639F9F-7497-45FF-A073-4CC5348ECAE0Q54315498-80C64E3A-9245-4D86-ACF0-8067B28F9ABA
P2860
Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Indolent mantle cell lymphoma ...... unoglobulin heavy chain genes.
@ast
Indolent mantle cell lymphoma ...... unoglobulin heavy chain genes.
@en
type
label
Indolent mantle cell lymphoma ...... unoglobulin heavy chain genes.
@ast
Indolent mantle cell lymphoma ...... unoglobulin heavy chain genes.
@en
prefLabel
Indolent mantle cell lymphoma ...... unoglobulin heavy chain genes.
@ast
Indolent mantle cell lymphoma ...... unoglobulin heavy chain genes.
@en
P2093
P1433
P1476
Indolent mantle cell lymphoma ...... unoglobulin heavy chain genes.
@en
P2093
David W Bahler
Joseph Locker
Laurentia Nodit
Samuel A Jacobs
Steven H Swerdlow
P304
P356
10.1053/S0046-8177(03)00410-6
P407
P577
2003-10-01T00:00:00Z